Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of PLN 3.12 billion. The enterprise value is 4.48 billion.

Market Cap	3.12B
Enterprise Value	4.48B

Important Dates

The last earnings date was Sunday, November 30, 2025.

Earnings Date	Nov 30, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Current Share Class	499.09M
Shares Outstanding	n/a
Shares Change (YoY)	-46.99%
Shares Change (QoQ)	+3.23%
Owned by Insiders (%)	9.78%
Owned by Institutions (%)	0.42%
Float	135.32M

Valuation Ratios

The trailing PE ratio is 11.54.

PE Ratio	11.54
Forward PE	n/a
PS Ratio	0.57
PB Ratio	1.46
P/TBV Ratio	2.06
P/FCF Ratio	n/a
P/OCF Ratio	77.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.70, with an EV/FCF ratio of -85.78.

EV / Earnings	16.56
EV / Sales	0.83
EV / EBITDA	8.70
EV / EBIT	12.67
EV / FCF	-85.78

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.64.

Current Ratio	1.31
Quick Ratio	0.67
Debt / Equity	0.64
Debt / EBITDA	3.24
Debt / FCF	-26.40
Interest Coverage	6.22

Financial Efficiency

Return on equity (ROE) is 14.42% and return on invested capital (ROIC) is 5.26%.

Return on Equity (ROE)	14.42%
Return on Assets (ROA)	4.19%
Return on Invested Capital (ROIC)	5.26%
Return on Capital Employed (ROCE)	9.83%
Revenue Per Employee	927,114
Profits Per Employee	45,858
Employee Count	5,599
Asset Turnover	1.40
Inventory Turnover	4.34

Taxes

In the past 12 months, Sopharma AD has paid 37.67 million in taxes.

Income Tax	37.67M
Effective Tax Rate	11.62%

Stock Price Statistics

The stock price has increased by +191.96% in the last 52 weeks. The beta is -0.10, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	+191.96%
50-Day Moving Average	6.03
200-Day Moving Average	4.79
Relative Strength Index (RSI)	68.34
Average Volume (20 Days)	816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of PLN 5.47 billion and earned 270.79 million in profits. Earnings per share was 0.97.

Revenue	5.47B
Gross Profit	1.26B
Operating Income	262.98M
Pretax Income	324.29M
Net Income	270.79M
EBITDA	380.20M
EBIT	262.98M
Earnings Per Share (EPS)	0.97

Full Income Statement

Balance Sheet

The company has 71.20 million in cash and 1.38 billion in debt, giving a net cash position of -1.31 billion.

Cash & Cash Equivalents	71.20M
Total Debt	1.38B
Net Cash	-1.31B
Net Cash Per Share	n/a
Equity (Book Value)	2.14B
Book Value Per Share	4.00
Working Capital	535.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.31 million and capital expenditures -92.58 million, giving a free cash flow of -52.28 million.

Operating Cash Flow	40.31M
Capital Expenditures	-92.58M
Free Cash Flow	-52.28M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.94%, with operating and profit margins of 4.80% and 4.95%.

Gross Margin	22.94%
Operating Margin	4.80%
Pretax Margin	5.92%
Profit Margin	4.95%
EBITDA Margin	6.94%
EBIT Margin	4.80%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.80%.

Dividend Per Share	0.23
Dividend Yield	1.80%
Dividend Growth (YoY)	-68.55%
Years of Dividend Growth	n/a
Payout Ratio	23.74%
Buyback Yield	46.99%
Shareholder Yield	48.79%
Earnings Yield	8.67%
FCF Yield	-1.67%

Dividend Details

Stock Splits

The last stock split was on July 10, 2025. It was a forward split with a ratio of 3.

Last Split Date	Jul 10, 2025
Split Type	Forward
Split Ratio	3

Scores

Sopharma AD has an Altman Z-Score of 2.49 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.49
Piotroski F-Score	5